Latest News
Premas Biotech and Oravax Medical to initiate testing of oral virus-like particle (VLP) vaccine candidate against Omicron variant of SARS-CoV 2 virus
1 December 2021 - Biopharmaceutical company Premas Biotech reported on Wednesday that its joint venture Oravax Medical is to begin tests on its oral virus-like particle (VLP) vaccine candidate against the Omicron variant of SARS-CoV 2 virus through p...
Resolve Biosciences announces appointment of Oliver Dick as COO
1 December 2021 - Spatial biology company Resolve Biosciences revealed on Wednesday that it has appointed Oliver Dick PhD as chief operating officer, reporting to the company's co-founder and CEO Jason T. Gammack.Dick will be responsible for ove...
Sobi and Selecta Biosciences complete enrolment for Phase 3 gout study
1 December 2021 - Biopharmaceutical company Swedish Orphan Biovitrum AB (Sobi) (STO:SOBI) and Selecta Biosciences Inc (NASDAQ:SELB), a clinical stage biotechnology company, announced on Wednesday the completion of enrolment for DISSOLVE I, a Phase 3 ...
Qiagen, DiaSorin Widen Access to Latent TB Testing in the US with FDA Approval of QuantiFERON-TB Gold Plus assay on Liaison XS
1 December 2021 - - The US Food and Drug Administration has approved the Liaison QuantiFERON-TB Gold Plus assay for use on DiaSorin's automated Liaison XS platform, German sample and assay technologies provider Qiagen (NYSE: QGEN) (Frankfurt Pri...
Sage Therapeutics and Biogen report positive 12-month data in ongoing Phase 3 open-label SHORELINE Study of Zuranolone 50mg in MDD patients
1 December 2021 - Biopharmaceutical company Sage Therapeutics Inc (Nasdaq: SAGE) and neuroscience company Biogen Inc (Nasdaq: BIIB) on Wednesday reported 12-month data for the cohort of major depressive disorder (MDD) patients (n=199), who received z...